CBT-I During Chemotherapy: What SleepCARE Found

At an oncology appointment, give sleep difficulty and daytime exhaustion separate entries in your notes. Ask what each proposed treatment is intended to change. Bring your notes so you can discuss the goals of any proposed sleep treatment.

Who was studied?

SleepCARE randomized 219 women receiving breast cancer chemotherapy, with at least six treatment weeks remaining, to six weeks of cognitive behavioral therapy for insomnia (CBT-I), bright light, both, or sleep education. All groups received sleep education. No minimum insomnia score was required. Analyses included 208 with any outcome data; 165 completed week six.¹

What changed?

The pooled CBT-I groups improved 2.19 points more on the 0–28 Insomnia Severity Index than groups without CBT-I (95% CI 1.05–3.33; adjusted P=0.002). Four primary tests used false-discovery-rate adjustment. Its standardized effect, 0.40, fell below the prespecified 0.50 clinical threshold. Neither intervention showed an added fatigue benefit; light’s overall insomnia result was inconclusive. Self-report, no masking and attrition limit certainty. Interaction analyses were exploratory and underpowered. This pooled comparison does not directly rank CBT-I alone against light alone.¹

What should I ask?

ESMO’s² 2023 cancer-insomnia guideline recommends considering brief behavioral therapy during active cancer treatment. Assessment should cover sleep patterns, daytime effects, other sleep disorders and contributing symptoms such as pain or hot flashes. Ask about a trained provider who can adapt treatment to your chemotherapy schedule and current symptoms. Its recommendation for standard CBT-I as usual care specifically addresses cancer survivors.²

Ask the clinician to explain the expected benefit, the time commitment and the review date. Do not copy a sleep-restriction schedule or buy light glasses on the strength of this article.²

Did I Do That in My Sleep? explains what CBT-I addresses and questions for finding appropriate care. Bring those questions to your oncology team: who provides treatment, how will the plan account for your health conditions, and what support is available between visits?